Earlier this month, the Partnership for Safe Medicines (PSM) released the L.E.A.D.E.R.’s Guide for Pharmacists to encourage pharmacists to take an active role in protecting the supply chain from counterfeit drugs. This effort is one of many to help curb the distribution of harmful and potentially deadly counterfeit drugs. Similarly, the Royal Pharmaceutical Society of Great Britain (RPSGB), Medicines and Healthcare products Regulatory Agency (MHRA) and the Dispensing Doctor’s Association (DDA) issued Counterfeit medicines: Guidance for pharmacists, explaining the background of counterfeit drugs, their production and distribution to pharmacists.

[...]

In the past two weeks, the Partnership for Safe Medicines issued two SafeMeds Alerts about counterfeit insulin pen needles and herbal medication adulterated with dangerously high levels of undeclared pharmaceuticals in the United Kingdom. It is tempting to disregard these alerts since the drugs were found in England, not the United States. But in today’s global environment, we are all at risk when these unsafe products move through the drug supply chain undetected.

[...]

A EURO MP has welcomed moves to protect people from a multi-billion pound counterfeit drugs industry which is feared to kill half a million people each year. Criminals are plying people suffering from cancer and heart disease as well as psychiatric illnesses with fake medicine which is virtually indistinguishable from the real thing. 18 April…

[...]

The European Commission is to prioritise and speed up moves to deal with the issue of counterfeit drugs in parallel trade and will launch a legislative initiative on the issue after the summer break, Commission Vice President Guenter Verheugen has announced in the European Parliament. At the end of December 2006, the Commission began a…

[...]

More than two million people in the UK now buy their drugs online, research published by the Royal Pharmaceutical Society (RPSGB) suggests. Up to a third of these medicines may be fake and could seriously damage people's health, it warns. The society has launched a new logo for online chemists so shoppers know which businesses…

[...]

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) unveiled an aggressive agenda Nov. 23 for combating the market in counterfeit medicines and medical devices. The plan targets both regulated and unregulated supply chains. The three-year anticounterfeit strategy calls for a complete assessment of current supply and distribution procedures in the UK and outlines the…

[...]